Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Genome & Company

Equities

A314130

KR7314130006

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-16 pm EDT 		5-day change 1st Jan Change
9,640 KRW +15.73% Intraday chart for Genome & Company +15.73% -22.82%
Jan. 24 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
GENOME & COMPANY
Other Biotechnology & Medical Research
+15.73%+15.73%-22.82%-33.10%-78.81% 91.92M - - -
  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Charts Genome & Company
  5. Relative Strength Chart